A dream-like psychedelic might help traumatized veterans reset their brains

Ibogaine treatment for traumatized veterans may help PTSD symptoms, and the strength of “mystical” experiences during dosing appears to predict recovery. The report highlights a study of 30 male Special Operations Veterans with a history of traumatic brain injury and combat exposure. Because ibogaine is not approved for medical use in the US, participants traveled to a clinic in Mexico for a single administration of ibogaine combined with magnesium sulfate, with outcomes assessed before treatment, immediately after, and one month later using clinical interviews and EEG. Higher scores on the Mystical Experiences Questionnaire (unity, sacredness, and related qualities like ineffability) matched larger reductions in PTSD severity, plus improvements in depression and anxiety. Brain physiology measures also shifted: peak alpha frequency slowed one month after treatment, which the researchers interpret as moving away from hyper-arousal. Key limitations noted include the open-label design with no placebo group, the small and all-male sample, and that the findings show correlation rather than proven causation.